Literature DB >> 19896530

The immunoregulatory role of dopamine: an update.

Chandrani Sarkar1, Biswarup Basu, Debanjan Chakroborty, Partha Sarthi Dasgupta, Sujit Basu.   

Abstract

The neurotransmitter dopamine (DA) is an important molecule bridging the nervous and immune systems. DA through autocrine/paracrine manner modulates the functions of immune effector cells by acting through its receptors present in these cells. DA also has unique and opposite effects on T cell functions. Although DA activates naïve or resting T cells, but it inhibits activated T cells. In addition, changes in the expression of DA receptors and their signaling pathways especially in T cells are associated with altered immune functions in disorders like schizophrenia and Parkinson's disease. These results suggest an immunoregulatory role of DA. Therefore, targeting DA receptors and their signaling pathways in these cells by using DA receptor agonists and antagonists may be useful for the treatment of diseases where DA induced altered immunity play a pathogenic role. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896530      PMCID: PMC2856781          DOI: 10.1016/j.bbi.2009.10.015

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  43 in total

1.  Cutting Edge: Stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation.

Authors:  Chandrani Sarkar; Shamik Das; Debanjan Chakroborty; Uttio Roy Chowdhury; Biswarup Basu; Partha Sarathi Dasgupta; Sujit Basu
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.

Authors:  Marco Cosentino; Anna Maria Fietta; Marco Ferrari; Emanuela Rasini; Raffaella Bombelli; Elena Carcano; Federica Saporiti; Federica Meloni; Franca Marino; Sergio Lecchini
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

3.  Catecholamines inhibit microglial nitric oxide production.

Authors:  J Y Chang; L Z Liu
Journal:  Brain Res Bull       Date:  2000-08       Impact factor: 4.077

4.  Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization.

Authors:  Debanjan Chakroborty; Uttio Roy Chowdhury; Chandrani Sarkar; Rathindranath Baral; Partha Sarathi Dasgupta; Sujit Basu
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

5.  Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen.

Authors:  Fiorenzo Mignini; Daniele Tomassoni; Enea Traini; Francesco Amenta
Journal:  J Neuroimmunol       Date:  2008-11-13       Impact factor: 3.478

6.  Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease.

Authors:  Shaji Theodore; Shuwen Cao; Pamela J McLean; David G Standaert
Journal:  J Neuropathol Exp Neurol       Date:  2008-12       Impact factor: 3.685

7.  Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays.

Authors:  Galina P Kirillova; Rebecca J Hrutkay; Michael R Shurin; Galina V Shurin; Irina L Tourkova; Michael M Vanyukov
Journal:  J Neurosci Methods       Date:  2008-08-05       Impact factor: 2.390

8.  Dopamine released by dendritic cells polarizes Th2 differentiation.

Authors:  Kazuhisa Nakano; Takehiro Higashi; Rie Takagi; Kumiko Hashimoto; Yoshiya Tanaka; Sho Matsushita
Journal:  Int Immunol       Date:  2009-03-30       Impact factor: 4.823

9.  Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis.

Authors:  Kazuhisa Nakano; Takehiro Higashi; Kumiko Hashimoto; Rie Takagi; Yoshiya Tanaka; Sho Matsushita
Journal:  Biochem Biophys Res Commun       Date:  2008-06-17       Impact factor: 3.575

10.  Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin's lymphoma.

Authors:  Elizabeth J Meredith; Michelle J Holder; Anders Rosén; Adrian Drake Lee; Martin J S Dyer; Nicholas M Barnes; John Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

View more
  103 in total

1.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

2.  Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells.

Authors:  Debanjan Chakroborty; Chandrani Sarkar; Hongmei Yu; Jiang Wang; Zhongfa Liu; Partha Sarathi Dasgupta; Sujit Basu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease.

Authors:  Natasa Kustrimovic; Emanuela Rasini; Massimiliano Legnaro; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-29       Impact factor: 4.147

4.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

5.  Neuropil pruning in Early-Course Schizophrenia: Immunological, Clinical, and Neurocognitive Correlates.

Authors:  Konasale M Prasad; Ashley M Burgess; Matcheri S Keshavan; Vishwajit L Nimgaonkar; Jeffrey A Stanley
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-11

6.  Association Between Interleukin-6 and Striatal Prediction-Error Signals Following Acute Stress in Healthy Female Participants.

Authors:  Michael T Treadway; Roee Admon; Amanda R Arulpragasam; Malavika Mehta; Samuel Douglas; Gordana Vitaliano; David P Olson; Jessica A Cooper; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2017-03-28       Impact factor: 13.382

7.  D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells.

Authors:  Biswarup Basu; Chandrani Sarkar; Debanjan Chakroborty; Subhalakshmi Ganguly; Saurav Shome; Partha Sarathi Dasgupta; Sujit Basu
Journal:  J Biol Chem       Date:  2010-06-30       Impact factor: 5.157

Review 8.  Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-17       Impact factor: 4.147

9.  Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αB-Crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model.

Authors:  Yang Zhang; Yujie Chen; Jiang Wu; Anatol Manaenko; Peng Yang; Jiping Tang; Weiling Fu; John H Zhang
Journal:  Stroke       Date:  2015-08-06       Impact factor: 7.914

Review 10.  β-amyloid, microglia, and the inflammasome in Alzheimer's disease.

Authors:  Maike Gold; Joseph El Khoury
Journal:  Semin Immunopathol       Date:  2015-08-07       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.